Understanding Lupus Anticoagulant (dRVVT) Confirm (LA 2) Ratio: Normal vs Optimal Ranges

?What is Lupus Anticoagulant (dRVVT) Confirm (LA 2) Ratio?

The lupus anticoagulant (LA) dRVVT confirm ratio is a specialized coagulation test used to detect antiphospholipid antibodies that may prolong clotting time. This ratio compares results from screening and confirm phases of the dilute Russell Viper Venom Time (dRVVT) test to differentiate lupus anticoagulant activity from other causes of prolonged clotting time. A ratio greater than 1.2 may suggest the presence of lupus anticoagulant.

!Why It Matters

Lupus anticoagulant is an antiphospholipid antibody that can increase the risk of thrombosis (blood clots) and complications in pregnancy, despite its paradoxical name. Detecting this marker is important for identifying patients at risk of recurrent thrombotic events and for appropriate anticoagulation management. A positive result may indicate antiphospholipid syndrome or autoimmune conditions and can guide clinical decision-making regarding anticoagulation therapy.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Recurrent blood clots (deep vein thrombosis or pulmonary embolism)
• Unexplained pregnancy loss or miscarriage
• Thrombotic events at young age
• Prolonged bleeding time on lab tests despite normal platelet count

How to Improve Your Levels

• 1Work with a hematologist or rheumatologist for diagnosis confirmation and management
• 2Follow prescribed anticoagulation therapy if indicated
• 3Monitor for signs of clotting or bleeding and report symptoms promptly
• 4Maintain regular follow-up testing as recommended by your healthcare provider
• 5Manage underlying autoimmune conditions if present
• 6Avoid prolonged immobility and consider compression stockings if at high thrombotic risk

When to Test

Testing is indicated when a patient has a prolonged activated partial thromboplastin time (aPTT) that does not correct with mixing studies, unexplained recurrent thrombosis, recurrent pregnancy loss, or when antiphospholipid syndrome is suspected. It is also recommended in patients with systemic lupus erythematosus or other autoimmune conditions.

Related Biomarkers